Long-Term Persistence with Newly-Initiated Warfarin or Non-VKA Oral Anticoagulant (NOAC) in Patients with Non-Valvular Atrial Fibrillation: Insights from the Prospective China-AF Registry

BACKGROUND: Oral anticoagulants (OACs) such as warfarin and non-VKA oral anticoagulants (NOACs) have been recommended for patients with atrial fibrillation (AF) who are at risk for stroke. Whether NOACs have a higher persistence than warfarin is still unclear. This is especially true in China. MATER...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Chang, Du, Xin, Jiang, Chao, He, Liu, Chang, San-Shuai, Guo, Xue-Yuan, Yu, Rong-Hui, Long, De-Yong, Bai, Rong, Liu, Nian, Sang, Cai-Hua, Jiang, Chen-Xi, Dong, Jian-Zeng, Lip, Gregory Y.H., Ma, Chang-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2019
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6475121/
https://www.ncbi.nlm.nih.gov/pubmed/30971681
http://dx.doi.org/10.12659/MSM.915875

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6475121/
https://www.ncbi.nlm.nih.gov/pubmed/30971681
http://dx.doi.org/10.12659/MSM.915875

Ejemplares similares